Pyxis Oncology, Inc. (PYXS) Tops Q2 EPS by 4c

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q2 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Analog Devices (ADI) call put ratio 1 call to 1.1 puts into quarter results
• Toll Brothers (TOL) call put ratio 2 calls to 1 put with a focus on September and January 175 calls